Daisuke Sugiura

6PUBLICATIONS
9CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 11, 2022
PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity.

Daisuke Sugiura, Il-Mi Okazaki, Takeo K Maeda

|Aug 26, 2021
PD-1 preferentially inhibits the activation of low-affinity T cells.

Kenji Shimizu, Daisuke Sugiura, Il-Mi Okazaki

|Sep 15, 2020
LAG-3: from molecular functions to clinical applications.

Takumi Maruhashi, Daisuke Sugiura, Il-Mi Okazaki

|Nov 15, 2019
Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells.

Natsumi Maeda, Takumi Maruhashi, Daisuke Sugiura

|Apr 20, 2019
Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses.

Daisuke Sugiura, Takumi Maruhashi, Il-Mi Okazaki

Pageof 1